Wayfinder Medical
Wayfinder Medical
Navigate what comes next
CONDITION GUIDE

Charcot-Marie-Tooth Disease

Charcot-Marie-Tooth Disease

Medical Overview

Charcot-Marie-Tooth disease (CMT) is the most common inherited neuromuscular disorder. It damages the peripheral nerves -- the nerves that connect your brain and spinal cord to the rest of your body -- causing progressive weakness and sensory loss, primarily in the feet, legs, hands, and arms.

CMT is not one disease. It is a group of over 100 genetically distinct conditions that all share the same basic pattern: slow, progressive weakness starting in the feet and working upward. The disease was first described in 1886 by three physicians whose names it carries. Despite the name, it has nothing to do with teeth.

CMT affects roughly 1 in 2,500 people worldwide, making it rare overall but the most common inherited nerve disorder. It occurs in all ethnic groups.

Types: About 80-90% of genetic abnormalities in CMT are caused by changes in just four genes: PMP22, GJB1, MPZ, and MFN2. The most common subtype, CMT1A, results from a duplication of the PMP22 gene on chromosome 17. What it does to nerves: CMT damages peripheral nerves in one of two ways (or both). It can destroy the myelin sheath that wraps around nerve fibers, slowing signal transmission. Or it can damage the axons themselves, weakening the signals entirely. Because the longest nerves are affected first, symptoms start in the feet and hands. Symptoms typically include: Symptoms usually appear in the first or second decade of life, though onset can occur at any age. CMT is progressive but usually slowly so. It rarely shortens lifespan. It does not affect intelligence.

Diagnosis & Treatment

Getting Diagnosed

CMT can take years to diagnose, especially milder cases. Early symptoms -- clumsiness, frequent ankle sprains, difficulty running -- are easily attributed to other causes.

Diagnostic process:

Treatment

There is no cure and no disease-modifying treatment for CMT. All treatment is about managing symptoms and maintaining function for as long as possible.

Physical and occupational therapy: Orthotics and bracing: Surgery: Pain management: Assistive devices: canes, walkers, wheelchairs (for some), adaptive tools for daily tasks. Research: Several clinical trials are underway investigating potential treatments, including gene therapy approaches and medications targeting PMP22 overexpression. No disease-modifying therapy has been approved yet, but this is an active area of research.

Accommodation Strategies

CMT creates a specific set of functional limitations centered on foot weakness, hand weakness, fatigue, and balance problems. These progress over time, so accommodations may need to evolve.

Workplace accommodations: The Job Accommodation Network (askjan.org) lists CMT-specific accommodation ideas.

Benefits & Disability

CMT can qualify for disability benefits, though the process depends heavily on the severity of symptoms and documented functional limitations.

Social Security Disability (SSDI/SSI)

The SSA evaluates CMT under Listing 11.14 -- Peripheral neuropathy, which requires documented disorganization of motor function in two extremities resulting in extreme limitation in standing, balancing, walking, or using upper extremities.

If you do not meet the listing criteria, you can still qualify through a Residual Functional Capacity (RFC) assessment showing that your combination of limitations -- weakness, balance problems, hand dysfunction, fatigue, pain -- prevents you from sustaining any full-time work.

Documentation strategy: Get nerve conduction study results, genetic confirmation of CMT, detailed physical therapy evaluations documenting functional decline over time, and physician statements about specific limitations (how far you can walk, how long you can stand, what you can do with your hands).

Workers' Compensation

CMT is a genetic condition, so workers' comp does not cover the disease itself. However, if workplace conditions or a workplace injury significantly worsens your symptoms, that aggravation may be compensable depending on your state.

Notable Public Figures

CMT does not have many high-profile public figures associated with it, partly because the condition is often invisible in its early stages and partly because it affects a relatively small population.

People within the CMT community -- including patient advocates, researchers, and everyday people living with the condition -- have done the heavy lifting on awareness. The Charcot-Marie-Tooth Association has worked to increase visibility through campaigns and events.

The relative lack of celebrity advocacy is itself part of the CMT experience. It is common enough to affect 1 in 2,500 people, but not well-known enough that most people have heard of it.

Newly Diagnosed

If you just found out you have CMT, here is what matters right now.

This is a slow disease. CMT progresses over years and decades, not weeks and months. You have time to learn, adapt, and plan. Do not let worst-case scenarios dominate your thinking. It is genetic, not something you caused. You inherited this condition. There is nothing you did or did not do that brought it on. If you plan to have children, genetic counseling can help you understand the inheritance pattern for your specific type. Start physical therapy now. Maintaining strength and flexibility is the most important thing you can do. A physical therapist familiar with neuromuscular conditions can design a program that works for you. Get fitted for orthotics if you need them. Ankle-foot orthoses can make a dramatic difference in walking stability and fall prevention. Do not wait until you have fallen multiple times. Know your medication risks. Certain drugs are neurotoxic and can rapidly worsen CMT. The CMT Association maintains a list of medications to avoid. Share this with every doctor, dentist, and pharmacist you see. Connect with the community. The Charcot-Marie-Tooth Association (cmtausa.org) is the primary patient organization. They maintain resources, fund research, and connect patients with each other and with knowledgeable clinicians. You are not alone. 1 in 2,500 people have this condition. That means there are roughly 130,000 people with CMT in the United States alone. They are living, working, raising families, and navigating the same challenges you are.

Culture & Media

CMT is almost completely absent from mainstream media. No major films, television shows, or bestselling books have centered on the condition. This invisibility reflects both the rarity of the condition and its often-subtle outward appearance -- people with CMT frequently look fine while dealing with significant functional limitations.

The name itself creates confusion. "Charcot-Marie-Tooth" is cumbersome, often mispronounced, and regularly assumed to be a dental condition. The CMT community has long debated whether a name change would help with awareness.

What representation exists lives primarily within the disability and rare disease advocacy spaces. Patient blogs, social media accounts, and YouTube channels are where real conversations about living with CMT happen.

Creators & Resources

Organizations

Support Communities

Medical Resources

Key Reading

Key Statistics